Sudden onset of severe urinary frequency with lower abdominal pain : This may indicate acute cystitis or other bladder pathology
On April 3, 2026, the Emirates Drug Establishment approved Foundayo, the worlds first oral GLP-1 pill for chronic weight management
Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: a randomized trial
The teams all-encompassing approach combines the powerful effects of GLP-1 medication with lifestyle modifications, nutritional guidance, and ongoing support to help patients navigate their weight loss journey with confidence
Lifestyle changes alone produce weight loss of 2-3% on average
It utilized search terms including "intermittent fasting," "time-restricted feeding," "alternate-day fasting," and "health effects of fasting"